Chung et al. [23] revealed that galectin-1 promoted the chemotherapy resistance of cisplatin in lung cancer by upregulating p38 mitogen-activated protein kinase, extracellular signal-regulated kinase and cyclooxygenase-2. The gene discussed is MAPK14; the disease is lung carcinoma.